CNW - it doesn't seem to matter how much revenue they generate, they can't seem to hold on to a tangible enough gross margin to generate a net profit margin. Its frustrating to follow, and I'm not even holding the stock. Thought it'd be a ripper stock for 2018, but the CY17 Q4 quarterly was very much "more of the same". Biggest worry with CNW is the length of contract. Recurring multi-cycle revenue will sit a lot better with the market than 2-3 yr tenures.
- Forums
- ASX - Short Term Trading
- Short Term Trading Week Starting: 29th Jan
Short Term Trading Week Starting: 29th Jan, page-351
Featured News
Featured News
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online